BioNexus Gene Lab (BGLC) Gains from Investment Securities (2020 - 2025)
BioNexus Gene Lab (BGLC) reported Gains from Investment Securities of $360.0 for Q4 2025, down 95.75% on a YoY basis from $8477.0 in Q4 2024, and down 91.41% sequentially from $4192.0 in Q3 2025.
BioNexus Gene Lab (BGLC) Gains from Investment Securities (2020 - 2025) Analysis & Trends
BioNexus Gene Lab (BGLC) has 6 years of Gains from Investment Securities data on file, last reported at $360.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 95.75% year-over-year to $360.0; the trailing twelve-month figure through Dec 2025 stood at $51855.0 (down 23.89% YoY), and the FY2025 full-year result was $22112.0, down 67.54% from the prior year.
- Gains from Investment Securities retreated to $360.0 in Q4 2025, from $4192.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $38826.0 in Q3 2024 to a low of -$21120.0 in Q3 2022.
- A 5-year average of $5438.5 and a median of $4192.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 15047.3% in 2021 and soared 366250.0% in 2024, its largest moves.
- Tracing BGLC's Gains from Investment Securities over 5 years: stood at -$11061.0 in 2021, then slumped by 90.94% to -$21120.0 in 2022, then soared by 99.98% to -$4.0 in 2023, then surged by 212025.0% to $8477.0 in 2024, then tumbled by 95.75% to $360.0 in 2025.
- Business Quant data shows BGLC's Gains from Investment Securities at $360.0 in Q4 2025, $4192.0 in Q3 2025, and $8477.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360.00 |
| Dec 31, 2025 | 360.00 |
| Sep 30, 2025 | 4,192.00 |
| Sep 30, 2025 | 4,192.00 |
| Dec 31, 2024 | 8,477.00 |
| Dec 31, 2024 | 8,477.00 |
| Sep 30, 2024 | 38,826.00 |
| Sep 30, 2024 | 38,826.00 |
| Jun 30, 2024 | 14,646.00 |
| Jun 30, 2024 | 14,646.00 |
| Mar 31, 2024 | 6,181.00 |
| Mar 31, 2024 | 6,181.00 |
| Jun 30, 2023 | -4.00 |
| Jun 30, 2023 | -4.00 |
| Mar 31, 2023 | 4.00 |
| Mar 31, 2023 | 4.00 |
| Sep 30, 2022 | -21,120.00 |
| Sep 30, 2022 | -21,120.00 |
| Jun 30, 2022 | 19,322.00 |
| Jun 30, 2022 | 19,322.00 |